Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Citalopram for IFN-Induced Depression in Hepatitis C
NCT00108563Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citalopram in major depressive disorder (MDD), sponsored by United States Department of Veterans Affairs. Started Oct 2003; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00108563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108563.